双極性障害の治療の世界市場

双極性障害の治療の世界市場は2030年までに67億米ドルに達する見込み

2024年に52億米ドルと推定される双極性障害の治療の世界市場は、分析期間2024-2030年にCAGR 4.2%で成長し、2030年には67億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである薬物療法は、CAGR 5.5%を記録し、分析期間終了時には25億米ドルに達すると予測されます。精神療法分野の成長率は、分析期間中CAGR 2.6％と推定されます。

米国市場は14億米ドルと推定、中国はCAGR 7.8％で成長予測

米国の双極性障害の治療市場は2024年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.8%で推移し、2030年には14億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と3.3%と予測されています。欧州では、ドイツがCAGR 2.4%で成長すると予測されています。

世界の双極性障害の治療市場- 主要動向と促進要因のまとめ

双極性障害の治療が世界のメンタルヘルスケアの枠組みで再注目されている理由とは？

躁病とうつ病が交互に発症する双極性障害は、診断率の上昇、精神疾患に対する意識の高まり、公衆衛生制度への大きな負担により、臨床的にも商業的にも注目を集めています。世界中で数百万人が罹患しているこの疾患は、しばしば機能障害や併存疾患を引き起こし、未治療のまま放置すると自殺リスクが高まるため、タイムリーで効果的な介入が不可欠となっています。メンタルヘルスサービスへのアクセスが拡大し、プライマリケアへの行動衛生の統合が進み、デスティグマティゼーションが進む中、包括的な双極性障害の治療に対する需要は世界的に高まっています。

治療プロトコールは一般的に長期的かつ多面的であり、気分安定薬、非定型抗精神病薬、抗うつ薬による薬理学的管理と心理社会的療法が含まれます。双極性障害の慢性的な性質と、継続的な維持、再発予防、副作用管理の必要性から、安全で効果的かつ個々の患者に合った治療オプションの戦略的重要性が強調されます。メンタルヘルスが世界のヘルスケアアジェンダの上位に位置する中、双極性障害は投資、研究、イノベーションの中心的な治療領域であり続けています。

薬物療法とデジタル精神医学の進歩は治療モデルをどのように変革しているか？

薬理学的イノベーションが双極性障害の治療の進歩を牽引し続けており、新世代の非定型抗精神病薬は安全性プロファイルを改善し、躁病エピソードとうつ病エピソードの両方にわたって気分を安定させる。長時間作用型の注射剤は、治療が困難な集団における維持療法と服薬アドヒアランスのために支持を集めています。これと並行して、睡眠調節、不安症状、認知機能障害を標的とした補助療法が、より微妙な症状コントロールのための薬理学的ツールキットを拡大しつつあります。

デジタル精神医学はまた、遠隔モニタリング、アプリベースの気分追跡、遠隔精神医療プラットフォーム、AIを活用した予測ツールなどを通じて、ケア提供の形を変えつつあります。これらのテクノロジーは、再発の早期発見を強化し、パーソナライズされた薬物調整をサポートし、自己管理戦略への関与を高める。臨床研究においては、デジタルフェノタイピングとリアルワールドエビデンスツールにより、臨床試験の登録が加速され、データの粒度が向上し、より患者中心の医薬品開発がサポートされています。これらの進歩が相まって、双極性障害のより継続的、積極的、統合的な治療経路が可能になりつつあります。

双極性障害の治療の需要が増加している市場と成長を牽引している患者セグメント

北米と欧州が双極性障害の治療の主要市場であり、強固なメンタルヘルスインフラ、保険適用、高い認知度に支えられています。米国は、抗精神病薬や気分安定薬の処方量が多いことに加え、デジタルメンタルヘルスプラットフォームの導入が進んでいることから、依然として大きな貢献をしています。アジア太平洋地域では、日本、オーストラリア、韓国、インドなどの国々で、診断率の上昇、公的メンタルヘルスイニシアチブ、精神科治療薬へのアクセス向上が市場拡大の原動力となっています。

主な患者層には、早期発症の双極性障害が多い青少年や若年成人、治療抵抗性やサイクルの速い成人などが含まれます。また、双極性障害の症状が認知機能の低下や後期うつ病と重なる可能性があり、専門的な管理が必要とされる高齢者層の需要も高まっています。不安障害、ADHD、薬物使用障害などの精神疾患の併存は、治療の複雑性をさらに高め、統合的で集学的な治療の必要性を促しています。

双極性障害の治療市場の世界的成長の原動力は？

双極性障害の治療市場の世界の成長の原動力は、メンタルヘルスに対する意識の高まり、スクリーニングプロトコルの改善、薬理療法と非薬理療法の両方へのアクセスの拡大です。メンタルヘルス予算を拡大し、偏見をなくし、行動療法をプライマリシステムに統合する政府の取り組みが、より広範な治療を促進しています。社会経済的ストレス要因やパンデミック後のメンタルヘルス動向によって増幅された気分障害の有病率の増加は、双極性障害を最優先の治療対象として強化しています。

医薬品イノベーション、デジタルヘルス統合、セクターを超えたパートナーシップは、治療の連続性を再構築し、より的を絞った持続可能な治療モデルを可能にしています。支払者と医療提供者が長期的な費用対効果の高い解決策を模索する中、アドヒアランス支援、機能的アウトカム、再発予防が重視されるようになっています。このような背景の中、この分野の軌跡を決定づける重要な疑問があります。双極性障害の治療のエコシステムは、ホリスティックで利用しやすく、患者に合わせたケアを提供するために十分な速さで進化することができるだろうか。

セグメント

治療タイプ（薬物療法、精神療法、電気けいれん療法、経頭蓋磁気刺激療法、その他の治療タイプ）、双極性障害タイプ（双極性障害i型、双極性障害II型、サイクロサイミック障害、その他の双極性障害タイプ）、エンドユーザー（病院、専門クリニック、メンタルヘルスセンター、外来手術センター）

調査対象企業の例（注目の合計42社）

• AbbVie Inc.
• Alkermes plc
• Allergan plc
• Amgen Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Gedeon Richter Plc
• GlaxoSmithKline plc（GSK）
• H. Lundbeck A/S
• Indivior PLC
• Intra-Cellular Therapies Inc.
• Janssen Pharmaceuticals Inc.
• Johnson & Johnson
• Minerva Neurosciences Inc.
• Novartis AG
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Sumitomo Pharma Co., Ltd.
• Teva Pharmaceutical Industries Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Bipolar Disorder Treatment Market to Reach US$6.7 Billion by 2030

The global market for Bipolar Disorder Treatment estimated at US$5.2 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Pharmacotherapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Psychotherapy segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.8% CAGR

The Bipolar Disorder Treatment market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Bipolar Disorder Treatment Market - Key Trends & Drivers Summarized

Why Is Bipolar Disorder Treatment Gaining Renewed Focus Within Global Mental Health Care Frameworks?

Bipolar disorder, characterized by alternating episodes of mania and depression, is gaining increased clinical and commercial attention due to rising diagnosis rates, growing awareness of psychiatric disorders, and its significant burden on public health systems. Affecting millions worldwide, the condition often leads to impaired functioning, comorbidities, and elevated suicide risk if left untreated-making timely and effective intervention critical. With expanding access to mental health services, integration of behavioral health into primary care, and destigmatization efforts, the demand for comprehensive bipolar disorder treatment is intensifying globally.

Treatment protocols are typically long-term and multifaceted, encompassing pharmacological management with mood stabilizers, atypical antipsychotics, and antidepressants, along with psychosocial therapies. The chronic nature of bipolar disorder and the need for ongoing maintenance, relapse prevention, and side effect management underscore the strategic importance of safe, efficacious, and individualized treatment options. As mental health rises on the global healthcare agenda, bipolar disorder remains a core therapeutic area for investment, research, and innovation.

How Are Advancements in Pharmacotherapy and Digital Psychiatry Transforming Treatment Models?

Pharmacological innovation continues to drive progress in bipolar disorder treatment, with new-generation atypical antipsychotics offering improved safety profiles and mood stabilization across both manic and depressive episodes. Long-acting injectable formulations are gaining traction for maintenance therapy and medication adherence in difficult-to-treat populations. In parallel, adjunctive therapies targeting sleep regulation, anxiety symptoms, and cognitive dysfunction are expanding the pharmacological toolkit for more nuanced symptom control.

Digital psychiatry is also reshaping care delivery through remote monitoring, app-based mood tracking, telepsychiatry platforms, and AI-enabled predictive tools. These technologies enhance early relapse detection, support personalized medication adjustments, and increase engagement in self-management strategies. In clinical research, digital phenotyping and real-world evidence tools are accelerating trial enrollment and improving data granularity-supporting more patient-centric drug development. Together, these advancements are enabling more continuous, proactive, and integrated treatment pathways for bipolar disorder.

Where Is Demand for Bipolar Disorder Treatment Increasing and Which Patient Segments Are Driving Growth?

North America and Europe are the leading markets for bipolar disorder treatment, supported by robust mental health infrastructure, insurance coverage, and high awareness levels. The U.S. remains a major contributor, with strong prescription volumes for antipsychotics and mood stabilizers, as well as growing adoption of digital mental health platforms. In Asia-Pacific, market expansion is being driven by increasing diagnosis rates, public mental health initiatives, and improved access to psychiatric medications in countries such as Japan, Australia, South Korea, and India.

Key patient segments include adolescents and young adults-where early-onset bipolar disorder often presents-and adults with treatment-resistant or rapid-cycling forms of the illness. Demand is also rising among elderly populations, where bipolar symptoms may overlap with cognitive decline or late-life depression, requiring specialized management. Psychiatric comorbidities such as anxiety, ADHD, and substance use disorders are further shaping treatment complexity and driving the need for integrated, multidisciplinary care.

What Is Fueling the Global Growth of the Bipolar Disorder Treatment Market?

The global growth of the bipolar disorder treatment market is fueled by rising mental health awareness, improved screening protocols, and expanding access to both pharmacological and non-pharmacological therapies. Government efforts to scale mental health budgets, reduce stigma, and integrate behavioral care into primary systems are fostering broader treatment reach. The increasing prevalence of mood disorders, amplified by socio-economic stressors and post-pandemic mental health trends, is reinforcing bipolar disorder as a high-priority therapeutic focus.

Pharmaceutical innovation, digital health integration, and cross-sector partnerships are reshaping the care continuum and enabling more targeted, sustainable treatment models. As payers and providers seek long-term cost-effective solutions, there is growing emphasis on adherence support, functional outcomes, and relapse prevention. Against this backdrop, a critical question defines the sector’s trajectory: Can the bipolar disorder treatment ecosystem evolve quickly enough to deliver holistic, accessible, and patient-tailored care-while addressing the lifelong nature and clinical complexity of this challenging mental health condition?

SCOPE OF STUDY:

The report analyzes the Bipolar Disorder Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Other Treatment Types); Bipolar Disorder Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, Other Bipolar Disorder Types); End-Use (Hospitals, Specialty Clinics, Mental Health Centers, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• AbbVie Inc.
• Alkermes plc
• Allergan plc
• Amgen Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Gedeon Richter Plc
• GlaxoSmithKline plc (GSK)
• H. Lundbeck A/S
• Indivior PLC
• Intra-Cellular Therapies Inc.
• Janssen Pharmaceuticals Inc.
• Johnson & Johnson
• Minerva Neurosciences Inc.
• Novartis AG
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Sumitomo Pharma Co., Ltd.
• Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Bipolar Disorder Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Mental Health Awareness Fuels Increased Diagnosis and Treatment of Bipolar Disorder
  • Next-Gen Mood Stabilizers and Atypical Antipsychotics Expand Therapeutic Options for Bipolar Management
  • Long-Acting Injectables and Sustained-Release Formulations Improve Medication Adherence
  • Multimodal Therapy Models Combining Pharmacological and Psychosocial Support Gain Clinical Favor
  • Growing Use of Digital Mental Health Tools Enhances Remote Monitoring and Patient Self-Management
  • Precision Psychiatry Approaches Incorporate Genomic and Biomarker-Guided Bipolar Treatment Strategies
  • Pediatric and Adolescent Bipolar Cases Prompt Demand for Age-Specific Dosing Protocols
  • Stigma Reduction Campaigns Encourage Treatment-Seeking Behavior Across Diverse Populations
  • Integration of Bipolar Screening in Primary Care and Telehealth Broadens Early Intervention Reach
  • Expanded Payer Coverage for Mental Health Services Increases Access to New-Generation Bipolar Drugs
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bipolar Disorder Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bipolar Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Pharmacotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Psychotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Mental Health Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Mental Health Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Mental Health Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Bipolar I Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Bipolar I Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Bipolar I Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Bipolar II Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Bipolar II Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Bipolar II Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Cyclothymic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Cyclothymic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Cyclothymic Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Bipolar Disorder Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Bipolar Disorder Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Bipolar Disorder Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• JAPAN
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• CHINA
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• EUROPE
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Bipolar Disorder Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• FRANCE
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• GERMANY
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Bipolar Disorder Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• INDIA
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Bipolar Disorder Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Bipolar Disorder Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
• AFRICA
  • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030

IV. COMPETITION